New Hydrogen CEO Steve Hill and Duke University Energy Policy Expert Discuss the Challenges and Opportunities of the Hydrogen Sector in the United States
05 nov. 2024 03h30 HE
|
NewHydrogen, Inc.
Dr. Jackson Ewing emphasizes the need for a robust policy framework to incentivize green hydrogen production and adoption SANTA CLARITA, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NewHydrogen,...
Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs
09 juin 2022 09h38 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, June 09, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
[Corrected] NAME, IMAGE, LIKENESS (NIL) POLICY UNLOCKS BOOSTA TRAINING’S PARTNERSHIP WITH DUKE UNIVERSITY MEN’S SOCCER HEAD COACH JOHN KERR AND PLAYERS
20 avr. 2022 13h30 HE
|
Boosta
Long Beach, CA, April 20, 2022 (GLOBE NEWSWIRE) -- Duke University Men’s Soccer Head Coach John Kerr and student-athletes currently on the Duke University Men’s Soccer team have partnered with...
Vivacitas Oncology Strengthens Its Neuro-Oncology Board With World-Class Advisor Dr. Katherine Peters, MD, PhD, FAAN
31 janv. 2022 09h00 HE
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, continues to grow its Neuro-Oncology...
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
20 août 2021 09h04 HE
|
Cryo-Cell International, Inc.
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area. MIAMI, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell...
Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials
10 mai 2021 09h00 HE
|
Cryo-Cell International, Inc.
MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell’s Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine...
Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University
26 févr. 2021 09h30 HE
|
Cryo-Cell International, Inc.
MIAMI, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells, has entered into a collaborative...
Cord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke University
11 juin 2020 16h10 HE
|
Cryo-Cell International, Inc.
OLDSMAR, Fla., June 11, 2020 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...
Cerner and Duke Clinical Research Institute Collaborate on Cardiac Risk App
23 août 2018 16h01 HE
|
Cerner Corporation
KANSAS CITY, Mo., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, collaborated with Duke Clinical Research Institute to develop an atherosclerotic cardiovascular...
IMPROVED SURVIVAL IN CHILDREN WITH GRAFT VERSUS HOST DISEASE WHO RESPOND TO MESOBLAST'S CELL THERAPY
15 févr. 2015 18h33 HE
|
Mesoblast
NEW YORK CITY and MELBOURNE, Australia, Feb. 15, 2015 (GLOBE NEWSWIRE) -- Results of 160 pediatric patients treated with Mesoblast's proprietary allogeneic Tier 1 product candidate MSC-100-IV for...